BIOCRYST PHARMACEUTICALS INC

Develops oral small-molecule drugs for rare diseases like hereditary angioedema.

BCRX | NDAQ

Overview

Corporate Details

ISIN(s):: US09058V1035
LEI:
Country:: United States of America
Address:: 4505 EMPEROR BOULEVARD, 27703 DURHAM
Website:: https://www.biocryst.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioCryst Pharmaceuticals Inc. is a commercial-stage biotechnology company focused on the discovery, development, and commercialization of novel medicines for rare diseases. The company specializes in creating oral small-molecule and protein therapeutics for patients with significant unmet medical needs, with a primary focus on hereditary angioedema (HAE) and other complement-mediated conditions. Founded in 1986, BioCryst utilizes a structure-guided drug design approach that combines biology, chemistry, and advanced technologies to develop first-in-class or best-in-class treatments. The company's mission is to improve patients' lives by advancing novel therapeutics globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOCRYST PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOCRYST PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BIOCRYST PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Dermapharm Holding SE Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.	Germany	DMP
Dermata Therapeutics, Inc. Develops OTC skin treatments using a unique delivery technology from freshwater sponges.	United States of America	DRMA
Design Therapeutics, Inc. Develops small molecule genomic medicines to treat serious genetic diseases by modulating genes.	United States of America	DSGN
Deutsche Biotech Innovativ AG Develops biomarker-driven therapeutics and diagnostics for serious diseases with unmet needs.	Germany	DBI
DEVA HOLDİNG A.Ş. Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.	Spain	DEVA
Devyser Diagnostics Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.	Sweden	DVYSR
DiaMedica Therapeutics Inc. Developing a novel protein therapy for acute ischemic stroke and preeclampsia.	United States of America	DMAC
Diamyd Medical AB (publ) Developing precision immunotherapies to preserve insulin in autoimmune diabetes.	Sweden	DMYD
Dianthus Therapeutics, Inc. /DE/ Developing selective antibody therapies for severe autoimmune diseases.	United States of America	DNTH
Diasorin Develops immunodiagnostic and molecular diagnostic kits and systems for healthcare and research.	Italy	DIA